CT-NIHSS mismatch does not correlate with MRI diffusion-perfusion mismatch

Stroke

Volumn 38, Issue 7, 2007, Pages 2079-2084

  Messé, Steven R ^a   Kasner, Scott E ^a   Chalela, Julio A ^b   Cucchiara, Brett ^a   Demchuk, Andrew M ^c   Hill, Michael D ^c   Warach, Steven ^d  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cerebral infarct; Computed tomography; Ischemic penumbra; Magnetic resonance imaging; Mismatch; Neuroradiology; Thrombolysis

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CALCULATION; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EXPERT; MULTIVARIATE ANALYSIS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34347363130     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.106.480731     Document Type: Article

References (26)

1. Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol. 2004;61:346-350.
2. Rother J, Schellinger PD, Gass A, Siebler M, Villringer A, Fiebach JB, Fiehler J, Jansen O, Kucinski T, Schoder V, Szabo K, Junge-Hulsing GJ, Hennerici M, Zeumer H, Sartor K, Weiller C, Hacke W. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke. 2002;33:2438-2445.
3. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM. Diffusion-and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol. 2002;51:28-37.
4. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S, for The Desmoteplase Study Group. The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66-73.
5. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W, for the DI. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006;37:1227-1231.
6. Thomalla G, Schwark C, Sobesky J, Bluhmki E, Fiebach JB, Fiehler J, Zaro Weber O, Kucinski T, Juettler E, Ringleb PA, Zeumer H, Weiller C, Hacke W, Schellinger PD, Rother J, for the MRI in Acute Stroke Study Group. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke. 2006;37:852-858.
7. Albers G, Thijs V, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg M, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks M, for the DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508-517.
8. Ruland S, Gorelick PB, Schneck M, Kim D, Moore CG, Leurgans S, Bhardwaj A. Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities: editorial comment: a statewide assessment of diagnostic and treatment capabilities. Stroke. 2002;33:1334-1340.
9. Singer OC, Sitzer M, du Mesnil de Rochemont R, Neumann-Haefelin T. Practical limitations of acute stroke MRI due to patient-related problems. Neurology. 2004;62:1848-1849.
10. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet. 2000;355:1670-1674.
11. Grotta J. NIHSS/EIC mismatch explains the >1/3 MCA conundrum. Stroke. 2003;21:21.
12. Pexman JHW, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, Hu WY, Buchan AM. Use of the alberta stroke program early CT score (ASPECTS) for assessing CT scans in patients with acute stroke. Am Jf Neuroradiol. 2001;22:1534-1542.
13. Girot M, Leclerc X, Gauvrit JY, Verdelho A, Pruvo JP, Leys D. Cerebral magnetic resonance imaging within 6 hours of stroke onset: inter- and intra-observer reproducibility. Cerebrovasc Dis. 2003;16:122-127.
14. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, Harnett K, Schwiderski U, Gammans R. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Ann Neurol. 2000;48:713-722.
15. Demchuk AM, Hill MD, Barber PA, Silver B, Patel SC, Levine SR, for the NINDS rtPA Stroke Study Group NIH. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke. 2005;36:2110-2115.
16. Dzialowski I, Hill MD, Coutts SB, Demchuk AM, Kent DM, Wunderlich O, von Kummer R. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke. 2006;37:973-978.
17. Kent DM, Hill MD, Ruthazer R, Coutts SB, Demchuk AM, Dzialowski I, Wunderlich O, von Kummer R. "Clinical-CT mismatch" and the response to systemic thrombolytic therapy in acute ischemic stroke. Stroke. 2005;36:1695-1699.
18. Weir NU, Pexman JHW, Hill MD, Buchan AM, on behalf of the CI. How well does ASPECTS predict the outcome of acute stroke treated with IV tPA? Neurology. 2006;67:516-518.
19. Patel SC, Levine SR, Tilley BC, Grotta JC, Lu M, Frankel M, Haley EC Jr, Brott TG, Broderick JP, Horowitz S, Lyden PD, Lewandowski CA, Marler JR, Welch KM. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. J Am Med Assoc. 2001;286:2830-2838.
20. Hartmann A, Rundek T, Mast H, Paik MC, Boden-Albala B, Mohr JP, Sacco RL. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology. 2001;57:2000-2005.
21. Schellinger P, Latour L, Wu C-S, Chalela J, Warach S The association between neurological deficit in acute ischemic stroke and mean transit time. Neuroradiology. 2006;V48:69-77.
22. Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, Wechsler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CM, Schulz GA, Buchan AM. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke. 2003;34:1925-1931.
23. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Consoli D, Wolfe CDA, Giroud M, Rudd A, Burger I, Ghetti A. Risk factors and outcome of subtypes of ischemic stroke. Data from a multicenter multinational hospital-based registry. The European Community Stroke Project. J Neurol Sci. 2006;244:143-150.
24. Maulaz AB, Bezerra DC, Bogousslavsky J. Posterior cerebral artery infarction from middle cerebral artery infarction. Arch Neurol. 2005;62:938-941.
25. Toni D, Del Duca R, Fiorelli M, Sacchetti M, Bastianello S, Giubilei F, Martinazzo C, Argentino C. Pure motor hemiparesis and sensorimotor stroke. Accuracy of very early clinical diagnosis of lacunar strokes. Stroke. 1994;25:92-96.
26. Davalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM, Silva Y, Serena J, Castillo J. The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology. 2004;62:2187-2192.